Management of infected bulk allografts with antibiotic-impregnated polymethylmethacrylate spacers

R H Quinn1, H J Mankin, D S Springfield

  • 1Department of Orthopedic Surgery, University of Connecticut School of Medicine/Hartford Hospital, USA.

Orthopedics
|November 2, 2001
PubMed

Insights

Infection after allograft transplantation is challenging. This study shows that antibiotic-impregnated polymethylmethacrylate (PMMA) spacers can successfully salvage limbs in 52% of patients, though infection eradication remains difficult.

Area of Science:

  • Orthopedics
  • Infectious Disease
  • Biomaterials

Background:

  • Deep infection following allograft transplantation presents a significant clinical challenge.
  • Effective management strategies are crucial for limb salvage and infection control.

Purpose of the Study:

  • To evaluate the efficacy of a management protocol involving allograft resection, antibiotic-impregnated polymethylmethacrylate (PMMA) spacer placement, and intravenous antibiotics for deep infections after allograft transplantation.
  • To determine the rate of infection eradication and limb salvage in patients treated with this protocol.

Main Methods:

  • A retrospective review of 27 patients who developed deep infection post-allograft transplantation.
  • Treatment included allograft resection, placement of an antibiotic-impregnated PMMA spacer, and intravenous antibiotics.
  • Outcomes assessed included infection eradication and limb salvage rates.

Main Results:

  • Overall infection eradication was achieved in 14 (52%) of 27 patients.
  • Among 11 patients not undergoing reimplantation, 5 required amputation due to persistent infection, and 4 retained the spacer at follow-up.
  • No significant correlation was found between successful eradication and patient demographics, infection characteristics, or treatment variables.

Conclusions:

  • The management of deep allograft infections using PMMA spacers offers a limb salvage rate of approximately 52%.
  • Despite this, deep infection following allograft transplantation continues to have a high failure rate.
  • Further research is needed to improve outcomes for these complex infections.

Related Concept Videos